-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – luxeptinib
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry luxeptinib Drug Details CG-806 is under development for the treatment of relasped/refractory acute myeloid...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ivaltinostat
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ivaltinostat Drug Details Ivaltinostat is under development for the treatment of metastatic pancreatic ductal...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CG-549
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CG-549 Drug Details CG-549 is under development for the treatment of complicated acute bacterial...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – olaptesed pegol
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry olaptesed pegol Drug Details Olaptesed pegol (NOX-A12) is under development for the treatment of ...